Cargando…

Utilization of MG‐ADL in myasthenia gravis clinical research and care [Image: see text]

The Myasthenia Gravis Activities of Living (MG‐ADL) scale is an 8‐item patient‐reported scale that measures myasthenia gravis (MG) symptoms and functional status. The objective of the current review is to summarize the psychometric properties of the MG‐ADL and published evidence of MG‐ADL use. A tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muppidi, Srikanth, Silvestri, Nicholas J., Tan, Robin, Riggs, Kimberly, Leighton, Trevor, Phillips, Glenn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302997/ https://www.ncbi.nlm.nih.gov/pubmed/34989427 http://dx.doi.org/10.1002/mus.27476

Ejemplares similares

Sensitivity of MG‐ADL for generalized weakness in myasthenia gravis
por: de Meel, R. H. P., et al.
Publicado: (2018)

Association Between Myasthenia Gravis–Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities
por: Dewilde, Sarah, et al.
Publicado: (2023)

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
por: Muppidi, Srikanth, et al.
Publicado: (2020)

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
por: Jacob, Saiju, et al.
Publicado: (2020)

Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)
por: Berrih-Aknin, Sonia, et al.
Publicado: (2023)

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG
por: Deymeer, Feza
Publicado: (2020)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
por: Dewilde, Sarah, et al.
Publicado: (2023)

MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis
por: Scott, Christiaan, et al.
Publicado: (2011)

Animal models of myasthenia gravis: utility and limitations
por: Mantegazza, Renato, et al.
Publicado: (2016)

Robotic-assisted minimally invasive thymectomy for myasthenia gravis with thymoma
por: Su, Katherine W., et al.
Publicado: (2022)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Should We Assess Diaphragmatic Function During Mechanical Ventilation Weaning in Guillain–Barré Syndrome and Myasthenia Gravis Patients?
por: Weiss, Nicolas
Publicado: (2021)

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
por: Muppidi, Srikanth, et al.
Publicado: (2019)

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO
por: Regnault, Antoine, et al.
Publicado: (2023)

Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study
por: Nowak, Richard J., et al.
Publicado: (2020)

Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)
por: Berrih-Aknin, Sonia, et al.
Publicado: (2021)

Invited Perspective: The [Formula: see text] and Mortality Dilemma Solved? Almost There!
por: Forastiere, Francesco, et al.
Publicado: (2021)

The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
por: Hughes, Tom, et al.
Publicado: (2023)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO
por: Regnault, Antoine, et al.
Publicado: (2023)

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
por: Mantegazza, Renato, et al.
Publicado: (2021)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
por: Phillips, Glenn, et al.
Publicado: (2022)

Invited Perspective: Forward Progress in Characterizing the Mortality Burden of [Formula: see text] for India
por: Adar, Sara D., et al.
Publicado: (2022)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales
por: Diez Porras, Laura, et al.
Publicado: (2022)

Pathomechanisms of Paraneoplastic Myasthenia Gravis
por: Ströbel, Philipp, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_r243eatu8kuie2oj0gq917grdl